SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

In one randomized, placebo-controlled trial containing 237 patients in China, patients with symptom durations of 10 days or less that received Remdesivir showed faster times to clinical improvement than those receiving placebo, although these differences did not reach statistical significance [ 165 ].

also in 111,027 other papers